OTTAWA: Canada is suspending the use of the Oxford-AstraZeneca vaccine. The reason is said to be the concern for people under the age of 55 as it may be linked to rare blood clots. Canada’s National Advisory Committee on Immunization recommended pausing the vaccination campaign for below 55 agers. 

NACI concerning safety reasons including the Canadian regions' stopped vaccination programme, which administers health in the country, announced the suspensions Monday. Dr. Shelley Deeks, Vice Chair of NACI marked his words saying “There is substantial uncertainty about the benefit of providing AstraZeneca Covid-19 vaccines to adults under 55 given the potential risks." The committee said that until a type of adverse event associated with the vaccine is investigated, its usage should for those below the age of 55 be suspended for a while. The AstraZeneca shot is authorized in around 70 countries and is backed project known as COVAX that aims to get corona vaccines to poorer countries. Chair of NACI Dr. Caroline Quach-Thanh said “This vaccine has had all the ups and downs. It looks like a roller coaster. We have no concerns with those who have received it so far."

Whereas Canadian regulators approved the Pfizer, Moderna, AstraZeneca, and Johnson & Johnson vaccines. The country has delayed vaccinating its civilians because of no domestic supply. PM Justin Trudeau’s government bet on seven different vaccines manufactured elsewhere and secured advance purchase agreements

Also Read:

Back to work: France reopens Libyan Embassy after seven years closure

Video: Philippines president trying to touch private part of female worker

Miscreants set fire to 400-year-old crematorium and Radha Govind Ashram in Bangladesh